Geron Corporation

Geron Corporationverified

GERN

Price:

$3.48

Market Cap:

$2.06B

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.[Read more]

Industry

Biotechnology

IPO Date

1996-07-31

Stock Exchange

NASDAQ

Ticker

GERN

The PE Ratio as of May 2024 (TTM) for Geron Corporation (GERN) is -10.24

According to Geron Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -10.24. This represents a change of 34.52% compared to the average of -7.61 of the last 4 quarters.

Geron Corporation (GERN) Historical PE Ratio (quarterly & annually)

How has GERN PE Ratio performed in the past?

The mean historical PE Ratio of Geron Corporation over the last ten years is 1.66K. The current -10.24 PE Ratio has changed -161.84% with respect to the historical average. Over the past ten years (40 quarters), GERN's PE Ratio was at its highest in in the September 2015 quarter at 4.01. The PE Ratio was at its lowest in in the September 2016 quarter at -25.14.

Quarterly (TTM)
Annual

Average

1.66K

Median

-6.53

Minimum

-13.99

Maximum

16.63K

Geron Corporation (GERN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Geron Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 97.72%

Maximum Annual PE Ratio = 16.63K

Minimum Annual Increase = -118961.51%

Minimum Annual PE Ratio = -13.99

Quarterly (TTM)
Annual
YearPE RatioChange
2023-6.540.08%
2022-6.5397.72%
2021-3.30-42.11%
2020-5.7140.28%
2019-4.07-37.71%
2018-6.53-36.37%
2017-10.27-7.89%
2016-11.15-100.07%
201516.63K-118961.51%
2014-13.99-6.32%

Geron Corporation (GERN) Average PE Ratio

How has GERN PE Ratio performed in the past?

The current PE Ratio of Geron Corporation (GERN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-5.46

5-year avg

-5.23

10-year avg

1.66K

Geron Corporation (GERN) PE Ratio vs. Peers

How is GERN’s PE Ratio compared to its peers?

Geron Corporation’s PE Ratio is less than Viking Therapeutics, Inc. (0), greater than TG Therapeutics, Inc. (-69.27), less than X4 Pharmaceuticals, Inc. (59.30), less than PDS Biotechnology Corporation (-1.40), less than Madrigal Pharmaceuticals, Inc. (-2.44), greater than Zura Bio Limited (-10.34), less than Enveric Biosciences, Inc. (-5.00), less than eFFECTOR Therapeutics, Inc. (-0.22), less than Immix Biopharma, Inc. (-0.21), less than Elevation Oncology, Inc. (-2.90), less than Sarepta Therapeutics, Inc. (-4.62), less than Hepion Pharmaceuticals, Inc. (686.76), less than PTC Therapeutics, Inc. (-0.15), less than CohBar, Inc. (-4.91), less than Ocean Biomedical, Inc. (-0.25), less than AVROBIO, Inc. (-0.25), less than null (2.23),

Build a custom stock screener for Geron Corporation (GERN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Geron Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Geron Corporation (GERN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Geron Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Geron Corporation's PE Ratio?

How is the PE Ratio calculated for Geron Corporation (GERN)?

What is the highest PE Ratio for Geron Corporation (GERN)?

What is the 3-year average PE Ratio for Geron Corporation (GERN)?

What is the 5-year average PE Ratio for Geron Corporation (GERN)?

How does the current PE Ratio for Geron Corporation (GERN) compare to its historical average?